GLP-1 Pipeline 2026: Obesity Drug Timeline
https://remypeptides.com/research/obesity-drug-pipeline-timeline-2026
Jun 29, 2026 · This page is the 2026 catalyst calendar for obesity drugs. It tracks filing windows, FDA decision timing, Phase 3 readouts, and post-approval launch checkpoints.
GLP-1 Drug Pipeline Tracker (2026) | FormBlends
https://formblends.com/pipeline
Apr 11, 2026 · Track every GLP-1 and next-gen weight loss compound in clinical trials. Phase data, trial results, and expected FDA timelines for 2026-2027.
Obesity Drug Approval Status 2026: FDA Tracker
https://remypeptides.com/research/obesity-drug-approval-tracker-2026
Jun 21, 2026 · Obesity Drug Approval Status 2026: FDA Tracker Track which obesity drugs are approved, filed, or still in Phase 3, then click through to each drug-specific status page for the current …
Obesity drug pipeline 2026: every GLP-1 and metabolic candidate in ...
https://thepeptideexaminer.com/pipeline
Apr 23, 2026 · Every obesity drug candidate in clinical development. Approved drugs, submitted filings, Phase 3 and Phase 2 candidates — with mechanism, latest readouts, and primary-source citations.
Obesity Drug Pipeline Insight 2026 - expertmarketresearch.com
https://www.expertmarketresearch.com/clinical-trials/obesity-drug-pipeline-insight
Apr 18, 2026 · Rising global obesity rates, increased investment in novel therapeutics, and advancements in GLP-1 receptor agonists and combination therapies are driving growth in the …
Obesity Drug Pipeline at ADA 2026: Retatrutide Matches Bariatric ...
https://www.techtimes.com/articles/317983/20260608/obesity-drug-pipeline-ada-2026-retatrutide-matches-bariatric-surgery-monthly-glp-1-debuts.htm
Jun 8, 2026 · Retatrutide reached 30.3% weight loss over two years; survodutide delivered 63% liver fat reduction. The American Diabetes Association's 86th Scientific Sessions concluded Monday in New …
GLP-1 Pipeline Tracker: Every Drug & Trial (2026)
https://dadstrengthdaily.com/glp1-pipeline-tracker/
4 days ago · A live tracker of every approved and pipeline GLP-1 and incretin drug: what each targets, its trial stage, peak weight loss, and what's next.
Every Obesity Peptide in the Pipeline: 2026 | RethinkPeptides
https://rethinkpeptides.com/articles/every-obesity-peptide-in-the-pipeline-a-2026-tracker
Mar 21, 2026 · This tracker covers every major peptide and peptide-adjacent obesity drug in Phase 2 or Phase 3 clinical trials as of March 2026. For background on how these drugs work, the pillar article …
Obesity drugs approach a major milestone, and Lilly may have a
https://www.cnbc.com/2026/06/25/obesity-drugs-approach-a-major-milestone-and-lilly-may-have-a-game-changer-ahead.html?msockid=384f2ac5d2c56e331a703d55d3a26f2c
Jun 25, 2026 · Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
Obesity Pharmacotherapy: An Urgent Need for Progressing Science, …
https://www.jacc.org/doi/10.1016/j.jacadv.2026.102713
Apr 6, 2026 · Key actionable items include the development of a roadmap for obesity research, standardization of obesity metrics and endpoints, ensuring equitable access to obesity medications, …
Learn what is the OWASP Top 10 and why does it matter for secure coding. A developer's guide to web app vulnerabilities, risks, and practical defense strategies.
Analysis of EIC Tech Report 2026: 25 early deep-tech signals to strengthen Europe. Bio-inspired AI, quantum communications, biomineralization, and surgical robotics. Who wins and who loses? Read the full review.
Nvidia reached $5.4 trillion capitalization, outpacing the 10 largest companies in Europe. Analysis of growth reasons, overheating risks, and forecasts for the AI chip market. Read the review.
Learn what is encryption and how does it work to protect your data. Discover symmetric vs asymmetric encryption, real-world impact, and practical security tips.
Learn what system design is and why it is important for building scalable, reliable software. Discover key principles and how to design systems that last.
MIT Technology Review Analysis: OpenAI's Share Drops to 46%, Protests and Regulatory Lawsuits. Learn how AI enters the survival of the fittest phase and what awaits the market in 90 days. Read the full analysis.
Analysis of trends, hidden risks, and geopolitical implications of Top 10 Emerging Technologies 2026. Who benefits from new developments and who loses. Read the analytics.
Figure AI introduced the humanoid robot Figure 02 with physical AI and OpenAI language model. The robot passed tests at BMW factories. Learn how humanoid robots are changing manufacturing.
Discover what is the best coding roadmap for beginners in 2026. A step-by-step guide to choosing a language, building projects, and landing your first job.
Learn how does quantum computing differ from classical computing. Compare bits vs qubits, strengths, use cases, and decide which paradigm fits your needs. Read now.